Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Immunopharmacology and Immunotoxicology
|
June 25, 2024
CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models
Dan Li, Song Shan, Xuhua Mao, et al.
Advanced Biology
|
February 28, 2025
CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1
Heping Jin, Zongyang Li, Xinwen Li, et al.
Animal Models and Experimental Medicine
|
June 14, 2024
Targeting ASK1 by CS17919 alleviates kidney- and liver-related diseases in murine models
Guoqiang Liao, Qianjiao Yang, Xuhua Mao, et al.
Anti-Cancer Drugs
|
April 19, 2019
Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
You Zhou, Chao Fu, Yidi Kong, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 15, 2018
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
Haige Ye, Aakash Desai, Shengjian Huang, et al.
Nature Communications
|
April 20, 2022
A natural allele of OsMS1 responds to temperature changes and confers thermosensitive genic male sterility
Lunying Wu, Xiaohui Jing, Baolan Zhang, et al.
International Journal of Endocrinology
|
February 24, 2023
CS27109, A Selective Thyroid Hormone Receptor-<i>β</i> Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models
Shengjian Huang, Zhou Deng, Wei Wang, et al.
International Immunopharmacology
|
October 22, 2019
Therapeutic treatment of a novel selective JAK3/JAK1/TBK1 inhibitor, CS12192, in rat and mouse models of rheumatoid arthritis
Song Shan, You Zhou, Jindi Yu, et al.
Frontiers in Endocrinology
|
February 6, 2023
Discovery of a novel, liver-targeted thyroid hormone receptor-β agonist, CS271011, in the treatment of lipid metabolism disorders
Suwen Lin, Shengjian Huang, Zhou Deng, et al.
Molecular Cancer Therapeutics
|
November 11, 2018
Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma
Carrie J Li, Changying Jiang, Yang Liu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Immunopharmacology and Immunotoxicology
|
June 25, 2024
CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models
Dan Li, Song Shan, Xuhua Mao, et al.
Advanced Biology
|
February 28, 2025
CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1
Heping Jin, Zongyang Li, Xinwen Li, et al.
Animal Models and Experimental Medicine
|
June 14, 2024
Targeting ASK1 by CS17919 alleviates kidney- and liver-related diseases in murine models
Guoqiang Liao, Qianjiao Yang, Xuhua Mao, et al.
Anti-Cancer Drugs
|
April 19, 2019
Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
You Zhou, Chao Fu, Yidi Kong, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 15, 2018
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
Haige Ye, Aakash Desai, Shengjian Huang, et al.
Nature Communications
|
April 20, 2022
A natural allele of OsMS1 responds to temperature changes and confers thermosensitive genic male sterility
Lunying Wu, Xiaohui Jing, Baolan Zhang, et al.
International Journal of Endocrinology
|
February 24, 2023
CS27109, A Selective Thyroid Hormone Receptor-<i>β</i> Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models
Shengjian Huang, Zhou Deng, Wei Wang, et al.
International Immunopharmacology
|
October 22, 2019
Therapeutic treatment of a novel selective JAK3/JAK1/TBK1 inhibitor, CS12192, in rat and mouse models of rheumatoid arthritis
Song Shan, You Zhou, Jindi Yu, et al.
Frontiers in Endocrinology
|
February 6, 2023
Discovery of a novel, liver-targeted thyroid hormone receptor-β agonist, CS271011, in the treatment of lipid metabolism disorders
Suwen Lin, Shengjian Huang, Zhou Deng, et al.
Molecular Cancer Therapeutics
|
November 11, 2018
Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma
Carrie J Li, Changying Jiang, Yang Liu, et al.
Page
of 3